CL2016001238A1 - Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. - Google Patents

Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment.

Info

Publication number
CL2016001238A1
CL2016001238A1 CL2016001238A CL2016001238A CL2016001238A1 CL 2016001238 A1 CL2016001238 A1 CL 2016001238A1 CL 2016001238 A CL2016001238 A CL 2016001238A CL 2016001238 A CL2016001238 A CL 2016001238A CL 2016001238 A1 CL2016001238 A1 CL 2016001238A1
Authority
CL
Chile
Prior art keywords
fragment
putative partial
putative
inhibits
virus
Prior art date
Application number
CL2016001238A
Other languages
Spanish (es)
Inventor
Nicole Tischler
Pinto Gonzalo Andres Barriga
Original Assignee
Fundación Ciencia Para La Vida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundación Ciencia Para La Vida filed Critical Fundación Ciencia Para La Vida
Priority to CL2016001238A priority Critical patent/CL2016001238A1/en
Priority to PCT/IB2017/053045 priority patent/WO2017203436A2/en
Publication of CL2016001238A1 publication Critical patent/CL2016001238A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12133—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
CL2016001238A 2016-05-23 2016-05-23 Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. CL2016001238A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2016001238A CL2016001238A1 (en) 2016-05-23 2016-05-23 Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment.
PCT/IB2017/053045 WO2017203436A2 (en) 2016-05-23 2017-05-23 Hanta virus gc fragments inhibiting the fusion of the virus with a cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2016001238A CL2016001238A1 (en) 2016-05-23 2016-05-23 Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment.

Publications (1)

Publication Number Publication Date
CL2016001238A1 true CL2016001238A1 (en) 2018-01-19

Family

ID=60411710

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001238A CL2016001238A1 (en) 2016-05-23 2016-05-23 Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment.

Country Status (2)

Country Link
CL (1) CL2016001238A1 (en)
WO (1) WO2017203436A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2020002568A1 (en) * 2020-10-05 2022-08-05 Univ Pontificia Catolica Chile Immunogenic formulation containing a modified bcg strain that expresses an andesvirus (andv) protein useful for preventing and treating hanta-andv virus infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298423A (en) * 1987-11-25 1994-03-29 The United States Of America As Represented By The Secretary Of The Army Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins

Also Published As

Publication number Publication date
WO2017203436A3 (en) 2018-02-01
WO2017203436A2 (en) 2017-11-30

Similar Documents

Publication Publication Date Title
SV2018005610A (en) SUBSTITUTED OXOPIRIDINE DERIVATIVES
BR112016020199A2 (en) Human plasma kallikrein inhibitor compound, pharmaceutical composition comprising said compound, kit and its use
CL2015002472A1 (en) As inhibitors of mutant idh-yl-oxazolidin-2-ones 3-pyrimidin-4.
BR112016030787A2 (en) chemical entity, pharmaceutical composition and its use
CL2018000565A1 (en) Compounds derived from pyridinone dicarboxamide, bromodomain inhibitors; pharmaceutical composition; pharmaceutical combination; Useful in the treatment of autoimmune, inflammatory, viral and cancer diseases, among others.
CL2018003826A1 (en) Use of a lignin fraction as an anti phytopathogenic agent and phytopathogenic compositions containing said agent.
BR112016024806A2 (en) private messaging application and associated methods.
NO20150805A1 (en) Self-closing, non-slip and tipping cup.
CL2016002151A1 (en) Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder
BR112017022438A2 (en) High performance fiberglass composition, fiberglass same and composite material.
BR112017009792A2 (en) anti-pdgf-b antibodies and methods of use
CL2016001238A1 (en) Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment.
ITUA20161865A1 (en) Use of lentinan for the treatment and prevention of endometriosis.
USD789656S1 (en) Swimsuit
CL2016002361A1 (en) Compounds derived from azabenzofuran; pharmaceutical composition, and its use as inhibitors of the function of the ns5b protein of hcv for the treatment of hepatitis c.
JP2017176931A5 (en)
CL2019001309A1 (en) Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. (divisional application n ° 01238-2016)
CL2019001310A1 (en) Fragment of the gc protein of the genus hantavirus that inhibits the fusion of said virus with a eukaryotic cell, which consists of the putative partial iii domain of gc, or the putative partial trunk region of gc; pharmaceutical composition comprising the fragment; and use of said fragment. (divisional application n ° 01238-2016)
BR112017020539A2 (en) hcv modified ns3 / ns4a polypeptides and uses thereof
IT201700072669A1 (en) Multi-purpose seating system
杨春芝 On The Translation of Chinese Culture-loaded Words in Chinese American Literature
ITUB201553195U1 (en) RING AND FRONT SEALING KIT.
CL2010000996A1 (en) Fragment of the gc protein of the genus hantavirus capable of inhibiting the fusion of said virus with a eukaryotic cell because it consists of domain iii of gc or putative domain iii of gc and the core region of gc protein; pharmaceutical composition comprising the fragment; use of said fragment.
TH176238B (en) Virus tracking system reports results in the genus Flavivirus.
TH181963B (en) Composite materials and the same manufacturing methods.